Amital H, Shoenfeld Y
Department of Medicine B, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Isr J Med Sci. 1993 Sep;29(9):593-7.
During the last 20 years considerable data have accumulated indicating that schizophrenia may have an autoimmune immunology. Patients with schizophrenia may have autoantibodies; in addition, cellular changes may occur that are compatible with autoimmunity, e.g., an increased number of CD5+ cells. If, indeed, schizophrenia does have an autoimmune pathogenesis, we should consider an alternative therapy based on immune system-manipulating drugs in addition to antipsychotic compounds.
在过去20年里,大量数据不断积累,表明精神分裂症可能存在自身免疫免疫学机制。精神分裂症患者可能存在自身抗体;此外,还可能出现与自身免疫相符的细胞变化,例如CD5+细胞数量增加。如果精神分裂症确实存在自身免疫发病机制,那么除了抗精神病药物外,我们还应考虑基于免疫系统调节药物的替代疗法。